Gerald Oppenheim

472 total citations
18 papers, 353 citations indexed

About

Gerald Oppenheim is a scholar working on Behavioral Neuroscience, Psychiatry and Mental health and Pharmacology. According to data from OpenAlex, Gerald Oppenheim has authored 18 papers receiving a total of 353 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Behavioral Neuroscience, 5 papers in Psychiatry and Mental health and 4 papers in Pharmacology. Recurrent topics in Gerald Oppenheim's work include Stress Responses and Cortisol (5 papers), Alzheimer's disease research and treatments (3 papers) and Estrogen and related hormone effects (2 papers). Gerald Oppenheim is often cited by papers focused on Stress Responses and Cortisol (5 papers), Alzheimer's disease research and treatments (3 papers) and Estrogen and related hormone effects (2 papers). Gerald Oppenheim collaborates with scholars based in Israel, India and United States. Gerald Oppenheim's co-authors include Richard P. Ebstein, Robert H. Belmaker, Joseph Zohar, Mark S. Segal, Baruch Shapira, Jochanan Stessman, Belmaker Rh, Bracha Shapira, Ayd Fj and ‌Barry Reisberg and has published in prestigious journals such as American Journal of Psychiatry, Biological Psychiatry and Life Sciences.

In The Last Decade

Gerald Oppenheim

18 papers receiving 329 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gerald Oppenheim Israel	12	127	81	68	62	57	18	353
Donald W. Ashbrook United States	7	69 0.5×	107 1.3×	116 1.7×	36 0.6×	138 2.4×	9	544
H.C. Stancer Canada	12	88 0.7×	21 0.3×	27 0.4×	50 0.8×	123 2.2×	24	446
Massimo C. Mauri Italy	11	105 0.8×	142 1.8×	21 0.3×	17 0.3×	56 1.0×	18	520
Åsta Cerin Sweden	6	34 0.3×	67 0.8×	65 1.0×	42 0.7×	93 1.6×	6	422
Petros Malitas Greece	10	130 1.0×	30 0.4×	25 0.4×	40 0.6×	74 1.3×	17	349
N. Bergemann Germany	9	150 1.2×	47 0.6×	29 0.4×	38 0.6×	23 0.4×	23	329
E. Windhager Austria	7	74 0.6×	50 0.6×	45 0.7×	20 0.3×	61 1.1×	13	213
Makoto Daiguji Japan	8	73 0.6×	50 0.6×	48 0.7×	9 0.1×	153 2.7×	13	386
N. Bjørum Denmark	13	178 1.4×	126 1.6×	160 2.4×	13 0.2×	46 0.8×	21	446
David R. Rubinow United States	6	25 0.2×	77 1.0×	68 1.0×	84 1.4×	55 1.0×	9	356

Countries citing papers authored by Gerald Oppenheim

Since Specialization

Citations

This map shows the geographic impact of Gerald Oppenheim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerald Oppenheim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerald Oppenheim more than expected).

Fields of papers citing papers by Gerald Oppenheim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerald Oppenheim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerald Oppenheim. The network helps show where Gerald Oppenheim may publish in the future.

Co-authorship network of co-authors of Gerald Oppenheim

This figure shows the co-authorship network connecting the top 25 collaborators of Gerald Oppenheim. A scholar is included among the top collaborators of Gerald Oppenheim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerald Oppenheim. Gerald Oppenheim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Oppenheim, Gerald. (1994). The Earliest Signs of Alzheimer's Disease. Journal of Geriatric Psychiatry and Neurology. 7(2). 116–120. 32 indexed citations

Reisberg, ‌Barry & Gerald Oppenheim. (1992). Alzheimer’s Disease—Clinical Course: Methodologic Implications for Pharmacologic Trials. International Psychogeriatrics. 4(3). 5–7. 3 indexed citations

Ebstein, Richard P., et al.. (1986). Age related decline in aluminum-activated human platelet adenylate cyclase: Post-receptor changes in cyclic AMP second messenger signal amplification in normal aging and dementia of the Alzheimer type. Life Sciences. 39(13). 1167–1175. 10 indexed citations

Ebstein, Richard P., et al.. (1986). The cyclic AMP second messenger system in man: The effects of heredity, hormones, drugs, aluminum, age and disease on signal amplification. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 10(3-5). 323–353. 28 indexed citations

Shapira, Baruch, et al.. (1985). Lack of efficacy of estrogen supplementation to imipramine in resistant female depressives. Biological Psychiatry. 20(5). 576–579. 65 indexed citations

Zohar, Joseph, Bracha Shapira, Gerald Oppenheim, Ayd Fj, & Belmaker Rh. (1985). Addition of estrogen to imipramine in female-resistant depressives.. PubMed. 21(3). 705–6. 14 indexed citations

Ebstein, Richard P., et al.. (1984). HORMONE STIMULATED ADENYLATE CYCLASE ACTIVITY IN AGED MAN AND AD/SDAT. Clinical Neuropharmacology. 7. S23–S23. 1 indexed citations

Oppenheim, Gerald, et al.. (1984). Acute desensitization of lymphocyte beta-adrenergic-stimulated adenylate cyclase in old age and Alzheimer's disease. Life Sciences. 35(17). 1795–1802. 13 indexed citations

Oppenheim, Gerald. (1984). A case of rapid mood cycling with estrogen: implications for therapy.. PubMed. 45(1). 34–5. 31 indexed citations

10.

Ebstein, Richard P., Gerald Oppenheim, & Jochanan Stessman. (1984). Alzheimer's disease: Isoproterenol and prostaglandin E1-stimulated cyclic AMP accumulation in lymphocytes. Life Sciences. 34(23). 2239–2243. 22 indexed citations

11.

Oppenheim, Gerald. (1983). Propranolol-Induced Depression: Mechanism and Management. Australian & New Zealand Journal of Psychiatry. 17(4). 400–402. 13 indexed citations

12.

Oppenheim, Gerald, et al.. (1983). [Personality of the parkinsonian. Clinical and psychometric approach].. PubMed. 141(2). 153–67. 1 indexed citations

13.

Oppenheim, Gerald. (1983). Propranolol-Induced Depression. Australian & New Zealand Journal of Psychiatry. 17(4). 400–402. 1 indexed citations

14.

Oppenheim, Gerald. (1983). Estrogen in the treatment of depression: neuropharmacological mechanisms.. PubMed. 18(6). 721–5. 42 indexed citations

15.

Oppenheim, Gerald. (1982). Physical illness diagnosed as psychiatric: Patients at special risk. General Hospital Psychiatry. 4(3). 241–243. 2 indexed citations

16.

Oppenheim, Gerald. (1982). Drug-induced rapid cycling: possible outcomes and management. American Journal of Psychiatry. 139(7). 939–941. 27 indexed citations

17.

Oppenheim, Gerald, Richard P. Ebstein, & Robert H. Belmaker. (1979). Effect of lithium on the physostigmine-induced behavioral syndrome and plasma cyclic GMP. Journal of Psychiatric Research. 15(2). 133–138. 36 indexed citations

18.

Oppenheim, Gerald. (1973). MUTISM AND HYPERTHERMIA IN A PATIENT TREATED WITH NEUROLEPTICS. The Medical Journal of Australia. 2(5). 228–229. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact